Blood transfusion services, COVID-19, Blood supply management, Blood demand, Blood donation


Objective: The present manuscript discusses our journey of providing safe BTS during this ongoing COVID-19 pandemic.

Methods: It was a single-center, retrospective type of study conducted over a period of 1 year (January 2020–December 2020) in the department of transfusion medicine. The number of donations (replacement and voluntary) was compared during the pre-COVID months with that during the COVID outbreak. The measures included but were not limited to various aspects of staff management, environmental factors, guidelines implementation, and innovative assertions for implementing COVID-19 appropriate behavior. Gradually, provisions were also made for the collection of the COVID convalescent plasma from the recovered donors as a part of the management guidelines issue by the Indian Council of Medical Research.

Results: COVID-19 pandemic has had a drastic negative impact on the blood donation but it has also highlighted the potential and the ability of the BTS to withstand such testing times.

Conclusion: COVID-19 has left a profound impact on the blood transfusion services. It has highlighted the importance of having a coping strategy in place to withstand such times without compromising the health and the needs of the patients.


Download data is not yet available.


Al Mahmasani L, Hodroj MH, Finianos A, Taher A. COVID-19 pandemic and transfusion medicine: The worldwide challenge and its implications. Ann Hematol 2021;100:1115-22. doi: 10.1007/s00277- 021-04441-y, PMID 33527161

Yahia AI. Management of blood supply and demand during the COVID-19 pandemic in King Abdullah Hospital, Bisha, Saudi Arabia. Transfus Apher Sci 2020;59:102836. doi: 10.1016/j.transci.2020.102836

Gupta D. Voluntary blood donation: Challenges in COVID-19 pandemic- Indian scenario. Ann Blood 2020;5:21. doi: 10.21037/aob-20-54

Ghosh A, Nundy S, Mallick TK. How India is dealing with COVID-19 pandemic. Sens Int 2020;1:100021. doi: 10.1016/j.sintl.2020.100021

Soni P. Effects of COVID-19 lockdown phases in India: An atmospheric perspective. Environ Dev Sustain 2021;23:12044-55. doi: 10.1007/ s10668-020-01156-4, PMID 33424429

Das SS, Biswas RN, Zaman RU. An insight into the encountered challenges and performances of a hospital-based blood transfusion service in Eastern India in the light of COVID-19 pandemic. Glob J Transfus Med 2020;6:163-8.

Stanworth SJ, New HV, Apelseth TO, Brunskill S, Cardigan R, Doree C, et al. Effects of the COVID-19 pandemic on supply and use of blood for transfusion. Lancet Haematol 2020;7:e756-64. doi: 10.1016/S2352- 3026(20)30186-1, PMID 32628911

Iqbal N, Haider K, Sundaram V, Radosevic J, Burnouf T, Seghatchian J, et al. Red blood cell transfusion and outcome in cancer. Transfus Apher Sci 2017;56:287-90. doi: 10.1016/j.transci.2017.05.014, PMID 28602484

Arcot PJ, Kumar K, Mukhopadhyay T, Subramanian A. Potential challenges faced by blood bank services during COVID-19 pandemic and their mitigative measures: The Indian scenario. Transfus Apher Sci 2020;59:102877. doi: 10.1016/j.transci.2020.102877

Jaikar BS. Impact of COVID 19 pandemic on blood transfusion services at a rural based district Hospital Blood-Bank India. IJPO 2021;8:50-4.

Senapati J, Aggarwal M, Louis L, Mirza SA, Kumar P, Dhawan R, et al. Transfusion practices during the COVID-19 pandemic: An experience from a hematology daycare in India. Transfus Apher Sci 2021;60:103025.

Evidence Based Advisory to Address Inappropriate Use of Convalescent Plasma in COVID-19 Patient. New Delhi: Indian Council of Medical Research; 2020.

Investigational COVID-19 Convalescent Plasma; Guidance for Industry. Vol. 17. United States: U.S. Department of Health and Human Services; 2022.

Fan BE, Ong KH, Chan SS, Young BE, Chong VC, Chen SP, et al. Blood and blood product use during COVID‐19 infection. Am J Hematol 2020;95:E158-60. doi: 10.1002/ajh.25823, PMID 32279352



How to Cite

CHOWDHRY, M., ANKITA SHARMA, S. AGRAWAL, and M. MISHRA. “BLOOD TRANSFUSION SERVICES IN COVID: SCALING THE UNSCALABLE”. Asian Journal of Pharmaceutical and Clinical Research, vol. 15, no. 6, June 2022, pp. 100-2, doi:10.22159/ajpcr.2022.v15i6.44498.



Original Article(s)